Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy

Cancer incidences are growing and cause millions of deaths worldwide. Cancer therapy is one of the most important challenges in medicine. Improving therapeutic outcomes from cancer therapy is necessary for increasing patients’ survival and quality of life. Adjuvant therapy using various types of ant...

Full description

Saved in:
Bibliographic Details
Published inJournal of cellular physiology Vol. 234; no. 8; pp. 12537 - 12550
Main Authors Mortezaee, Keywan, Salehi, Ensieh, Mirtavoos‐mahyari, Hanifeh, Motevaseli, Elahe, Najafi, Masoud, Farhood, Bagher, Rosengren, Rhonda J., Sahebkar, Amirhossein
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.08.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cancer incidences are growing and cause millions of deaths worldwide. Cancer therapy is one of the most important challenges in medicine. Improving therapeutic outcomes from cancer therapy is necessary for increasing patients’ survival and quality of life. Adjuvant therapy using various types of antibodies or immunomodulatory agents has suggested modulating tumor response. Resistance to apoptosis is the main reason for radioresistance and chemoresistance of most of the cancers, and also one of the pivotal targets for improving cancer therapy is the modulation of apoptosis signaling pathways. Apoptosis can be induced by intrinsic or extrinsic pathways via stimulation of several targets, such as membrane receptors of tumor necrosis factor‐α and transforming growth factor‐β, and also mitochondria. Curcumin is a naturally derived agent that induces apoptosis in a variety of different tumor cell lines. Curcumin also activates redox reactions within cells inducing reactive oxygen species (ROS) production that leads to the upregulation of apoptosis receptors on the tumor cell membrane. Curcumin can also upregulate the expression and activity of p53 that inhibits tumor cell proliferation and increases apoptosis. Furthermore, curcumin has a potent inhibitory effect on the activity of NF‐κB and COX‐2, which are involved in the overexpression of antiapoptosis genes such as Bcl‐2. It can also attenuate the regulation of antiapoptosis PI3K signaling and increase the expression of MAPKs to induce endogenous production of ROS. In this paper, we aimed to review the molecular mechanisms of curcumin‐induced apoptosis in cancer cells. This action of curcumin could be applicable for use as an adjuvant in combination with other modalities of cancer therapy including radiotherapy and chemotherapy.
AbstractList Cancer incidences are growing and cause millions of deaths worldwide. Cancer therapy is one of the most important challenges in medicine. Improving therapeutic outcomes from cancer therapy is necessary for increasing patients' survival and quality of life. Adjuvant therapy using various types of antibodies or immunomodulatory agents has suggested modulating tumor response. Resistance to apoptosis is the main reason for radioresistance and chemoresistance of most of the cancers, and also one of the pivotal targets for improving cancer therapy is the modulation of apoptosis signaling pathways. Apoptosis can be induced by intrinsic or extrinsic pathways via stimulation of several targets, such as membrane receptors of tumor necrosis factor-α and transforming growth factor-β, and also mitochondria. Curcumin is a naturally derived agent that induces apoptosis in a variety of different tumor cell lines. Curcumin also activates redox reactions within cells inducing reactive oxygen species (ROS) production that leads to the upregulation of apoptosis receptors on the tumor cell membrane. Curcumin can also upregulate the expression and activity of p53 that inhibits tumor cell proliferation and increases apoptosis. Furthermore, curcumin has a potent inhibitory effect on the activity of NF-κB and COX-2, which are involved in the overexpression of antiapoptosis genes such as Bcl-2. It can also attenuate the regulation of antiapoptosis PI3K signaling and increase the expression of MAPKs to induce endogenous production of ROS. In this paper, we aimed to review the molecular mechanisms of curcumin-induced apoptosis in cancer cells. This action of curcumin could be applicable for use as an adjuvant in combination with other modalities of cancer therapy including radiotherapy and chemotherapy.
Cancer incidences are growing and cause millions of deaths worldwide. Cancer therapy is one of the most important challenges in medicine. Improving therapeutic outcomes from cancer therapy is necessary for increasing patients' survival and quality of life. Adjuvant therapy using various types of antibodies or immunomodulatory agents has suggested modulating tumor response. Resistance to apoptosis is the main reason for radioresistance and chemoresistance of most of the cancers, and also one of the pivotal targets for improving cancer therapy is the modulation of apoptosis signaling pathways. Apoptosis can be induced by intrinsic or extrinsic pathways via stimulation of several targets, such as membrane receptors of tumor necrosis factor-α and transforming growth factor-β, and also mitochondria. Curcumin is a naturally derived agent that induces apoptosis in a variety of different tumor cell lines. Curcumin also activates redox reactions within cells inducing reactive oxygen species (ROS) production that leads to the upregulation of apoptosis receptors on the tumor cell membrane. Curcumin can also upregulate the expression and activity of p53 that inhibits tumor cell proliferation and increases apoptosis. Furthermore, curcumin has a potent inhibitory effect on the activity of NF-κB and COX-2, which are involved in the overexpression of antiapoptosis genes such as Bcl-2. It can also attenuate the regulation of antiapoptosis PI3K signaling and increase the expression of MAPKs to induce endogenous production of ROS. In this paper, we aimed to review the molecular mechanisms of curcumin-induced apoptosis in cancer cells. This action of curcumin could be applicable for use as an adjuvant in combination with other modalities of cancer therapy including radiotherapy and chemotherapy.Cancer incidences are growing and cause millions of deaths worldwide. Cancer therapy is one of the most important challenges in medicine. Improving therapeutic outcomes from cancer therapy is necessary for increasing patients' survival and quality of life. Adjuvant therapy using various types of antibodies or immunomodulatory agents has suggested modulating tumor response. Resistance to apoptosis is the main reason for radioresistance and chemoresistance of most of the cancers, and also one of the pivotal targets for improving cancer therapy is the modulation of apoptosis signaling pathways. Apoptosis can be induced by intrinsic or extrinsic pathways via stimulation of several targets, such as membrane receptors of tumor necrosis factor-α and transforming growth factor-β, and also mitochondria. Curcumin is a naturally derived agent that induces apoptosis in a variety of different tumor cell lines. Curcumin also activates redox reactions within cells inducing reactive oxygen species (ROS) production that leads to the upregulation of apoptosis receptors on the tumor cell membrane. Curcumin can also upregulate the expression and activity of p53 that inhibits tumor cell proliferation and increases apoptosis. Furthermore, curcumin has a potent inhibitory effect on the activity of NF-κB and COX-2, which are involved in the overexpression of antiapoptosis genes such as Bcl-2. It can also attenuate the regulation of antiapoptosis PI3K signaling and increase the expression of MAPKs to induce endogenous production of ROS. In this paper, we aimed to review the molecular mechanisms of curcumin-induced apoptosis in cancer cells. This action of curcumin could be applicable for use as an adjuvant in combination with other modalities of cancer therapy including radiotherapy and chemotherapy.
Author Najafi, Masoud
Salehi, Ensieh
Motevaseli, Elahe
Mortezaee, Keywan
Rosengren, Rhonda J.
Mirtavoos‐mahyari, Hanifeh
Sahebkar, Amirhossein
Farhood, Bagher
Author_xml – sequence: 1
  givenname: Keywan
  surname: Mortezaee
  fullname: Mortezaee, Keywan
  organization: School of Medicine, Kurdistan University of Medical Sciences
– sequence: 2
  givenname: Ensieh
  surname: Salehi
  fullname: Salehi, Ensieh
  organization: School of Medicine, Tehran University of Medical Sciences
– sequence: 3
  givenname: Hanifeh
  surname: Mirtavoos‐mahyari
  fullname: Mirtavoos‐mahyari, Hanifeh
  organization: Faculty of Medicine, Tehran University of Medical Sciences
– sequence: 4
  givenname: Elahe
  surname: Motevaseli
  fullname: Motevaseli, Elahe
  organization: School of Advanced Technologies in Medicine, Tehran University of Medical Sciences
– sequence: 5
  givenname: Masoud
  surname: Najafi
  fullname: Najafi, Masoud
  email: najafi_ma@yahoo.com
  organization: School of Paramedical Sciences, Kermanshah University of Medical Science
– sequence: 6
  givenname: Bagher
  surname: Farhood
  fullname: Farhood, Bagher
  email: bffarhood@gmail.com
  organization: Faculty of Paramedical Sciences, Kashan University of Medical Sciences
– sequence: 7
  givenname: Rhonda J.
  surname: Rosengren
  fullname: Rosengren, Rhonda J.
  organization: University of Otago
– sequence: 8
  givenname: Amirhossein
  orcidid: 0000-0002-8656-1444
  surname: Sahebkar
  fullname: Sahebkar, Amirhossein
  email: sahebkara@mums.ac.ir, amir_saheb2000@yahoo.com
  organization: School of Pharmacy, Mashhad University of Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30623450$$D View this record in MEDLINE/PubMed
BookMark eNp1kT9v2zAUxInAReO4HfIFAgJZ2kEx-SjKYrbAaJoULtyhnQnymUJoSKJCSij87av4z2Kk0xvud4eHuysyaUPrCLnm7I4zBvMtdndQcoALMuVMLbK8kDAh01HjmZI5vyRXKW0ZY0oJ8ZFcClaAyCWbkvVPhy-m9alJNFTUdKHrQ_KJNmEz1Kb3oaV2R3GIODS-vafPTVd73AuJViFSNC26SPsXF023-0Q-VKZO7vPxzsifx2-_l0_Zav39efmwylBIARmWCyxYteGYw0ZxYRVKyBkKa6SyYKVDY52UixIRWGmZ45UEZ5VQJYCsxIx8OeR2MbwOLvW68QldXZvWhSFp4IUsikKwckRvz9BtGGI7fqcBOM9VuRAwUjdHarCN2-gu-sbEnT5VNQLzA4AxpBRdpdH3-x76aHytOdNvY-hxDL0fY3R8PXOcQt9jj-l_fe12_wf1j-Wvg-MfdFCXwA
CitedBy_id crossref_primary_10_1155_2022_7277562
crossref_primary_10_1007_s11240_024_02802_9
crossref_primary_10_3390_nano11020489
crossref_primary_10_1186_s13045_021_01096_0
crossref_primary_10_1016_j_carbpol_2024_122328
crossref_primary_10_1016_j_procbio_2022_09_001
crossref_primary_10_1177_1934578X241239825
crossref_primary_10_3724_SP_J_1329_2024_04014
crossref_primary_10_1007_s00210_024_03502_z
crossref_primary_10_1007_s10068_022_01042_x
crossref_primary_10_3389_fnut_2023_1163950
crossref_primary_10_3390_molecules30010043
crossref_primary_10_1007_s00204_019_02550_2
crossref_primary_10_3390_molecules26175219
crossref_primary_10_1002_jbm_a_37288
crossref_primary_10_1042_BSR20200257
crossref_primary_10_1155_2021_1969863
crossref_primary_10_15407_dopovidi2023_03_073
crossref_primary_10_2174_1874471015666220623104316
crossref_primary_10_1007_s40204_021_00178_z
crossref_primary_10_1002_tox_23977
crossref_primary_10_1038_s41598_024_81375_1
crossref_primary_10_2147_IJN_S369761
crossref_primary_10_17650_2313_805X_2020_7_1_8_16
crossref_primary_10_34172_jsums_2022_24
crossref_primary_10_3390_ijms20040905
crossref_primary_10_3389_fcell_2022_1036809
crossref_primary_10_2174_0929867329666221007115809
crossref_primary_10_1007_s11357_023_00740_6
crossref_primary_10_3390_ijms232314957
crossref_primary_10_4103_pm_pm_53_20
crossref_primary_10_3389_fphar_2024_1343193
crossref_primary_10_1155_2022_1620802
crossref_primary_10_3390_coatings14101267
crossref_primary_10_1002_mnfr_202300479
crossref_primary_10_2147_OTT_S242344
crossref_primary_10_1016_j_intimp_2024_112066
crossref_primary_10_3892_ol_2023_14200
crossref_primary_10_3389_fimmu_2022_1041138
crossref_primary_10_3389_fphar_2022_1078303
crossref_primary_10_3390_pharmaceutics13122102
crossref_primary_10_1049_2023_1745877
crossref_primary_10_1021_acsomega_3c03405
crossref_primary_10_1016_j_pestbp_2022_105258
crossref_primary_10_1080_15287394_2024_2368619
crossref_primary_10_1186_s12935_021_02099_0
crossref_primary_10_1002_jbt_22633
crossref_primary_10_1016_j_ntm_2025_100076
crossref_primary_10_2174_0929867329666220210145033
crossref_primary_10_3390_molecules28135082
crossref_primary_10_1021_acsptsci_4c00518
crossref_primary_10_1016_j_ijpharm_2022_121622
crossref_primary_10_2478_sjecr_2019_0016
crossref_primary_10_32749_nucleodoconhecimento_com_br_health_phenolic_compounds
crossref_primary_10_3390_nano12142404
crossref_primary_10_1002_jsde_12756
crossref_primary_10_1177_15593258231203585
crossref_primary_10_2147_IJN_S476686
crossref_primary_10_2174_1874471015666220901142858
crossref_primary_10_3389_fgene_2022_953997
crossref_primary_10_1002_ptr_6577
crossref_primary_10_1038_s41598_019_54284_x
crossref_primary_10_1016_j_procbio_2023_11_006
crossref_primary_10_3389_fphar_2020_585413
crossref_primary_10_3389_fphar_2022_889816
crossref_primary_10_1177_09731296241298344
crossref_primary_10_1155_2024_9347381
crossref_primary_10_4103_jrptps_JRPTPS_98_19
crossref_primary_10_1016_j_carbpol_2023_121434
crossref_primary_10_1007_s12010_024_05094_z
crossref_primary_10_1016_j_jtherbio_2024_103968
crossref_primary_10_1016_j_mtbio_2024_101276
crossref_primary_10_1016_j_bbrc_2023_149274
crossref_primary_10_1016_j_jaim_2024_101013
crossref_primary_10_1016_j_ejmech_2019_111687
crossref_primary_10_1002_ptr_7417
crossref_primary_10_1021_acsanm_4c02800
crossref_primary_10_1155_2021_8972074
crossref_primary_10_3389_fphar_2020_00792
crossref_primary_10_1093_burnst_tkae061
crossref_primary_10_3390_biomedicines10020312
crossref_primary_10_1016_j_radonc_2023_109689
crossref_primary_10_2174_0115680096277126240102060617
crossref_primary_10_1007_s11596_021_2469_0
crossref_primary_10_3390_pharmaceutics11080373
crossref_primary_10_1002_biof_1823
crossref_primary_10_1016_j_jconrel_2022_05_035
crossref_primary_10_3389_fonc_2021_672490
crossref_primary_10_2174_1871520620666200203143803
crossref_primary_10_1038_s41420_023_01752_z
crossref_primary_10_3390_antiox11112202
crossref_primary_10_1016_j_biopha_2022_114084
crossref_primary_10_7717_peerj_12303
crossref_primary_10_3389_fphar_2022_920514
crossref_primary_10_1016_j_heliyon_2024_e38021
crossref_primary_10_1039_D4RA01246A
crossref_primary_10_1111_jcmm_14966
crossref_primary_10_3390_ph17050574
crossref_primary_10_3390_ijms20051239
crossref_primary_10_1007_s40204_022_00197_4
crossref_primary_10_31083_j_fbl2810244
crossref_primary_10_1007_s13233_025_00367_w
crossref_primary_10_1111_cbdd_14468
crossref_primary_10_1016_j_envpol_2021_116495
crossref_primary_10_1186_s12951_023_01779_5
crossref_primary_10_1002_mco2_249
crossref_primary_10_3390_biom12111600
crossref_primary_10_3390_ph15070843
crossref_primary_10_3390_nu15061363
crossref_primary_10_1142_S0192415X24500241
crossref_primary_10_34172_apb_2023_035
crossref_primary_10_1007_s12291_025_01304_5
crossref_primary_10_1080_01635581_2022_2139398
crossref_primary_10_1155_2023_5537610
crossref_primary_10_1080_08982104_2022_2153138
crossref_primary_10_1016_j_bbrc_2023_08_016
crossref_primary_10_2174_1568009619666191019143539
crossref_primary_10_2174_1385272824999200802025233
crossref_primary_10_1186_s12935_021_01773_7
crossref_primary_10_1007_s10517_021_05161_z
crossref_primary_10_2174_1871527321666220119105836
crossref_primary_10_5812_ijpr_150978
crossref_primary_10_3389_fphar_2021_784335
crossref_primary_10_1021_acs_molpharmaceut_0c00718
crossref_primary_10_3390_molecules24224179
crossref_primary_10_1016_j_phrs_2021_106005
crossref_primary_10_1038_s41416_019_0651_y
crossref_primary_10_3389_fonc_2022_939646
crossref_primary_10_1016_j_bbrc_2021_08_089
crossref_primary_10_1002_smll_202405752
crossref_primary_10_3390_nano12203619
crossref_primary_10_1002_ptr_6642
crossref_primary_10_1371_journal_pcbi_1008066
crossref_primary_10_3389_fbioe_2020_00050
crossref_primary_10_3934_agrfood_2021045
crossref_primary_10_1016_j_biopha_2022_113609
crossref_primary_10_1016_j_mad_2019_111191
crossref_primary_10_1080_1061186X_2022_2141755
crossref_primary_10_1016_j_jff_2022_105202
crossref_primary_10_1080_15384047_2022_2058862
crossref_primary_10_3389_fphar_2024_1389922
crossref_primary_10_2174_0109298673248404231006052436
crossref_primary_10_1016_j_bioorg_2025_108264
crossref_primary_10_1007_s11357_024_01092_5
crossref_primary_10_1016_j_colsurfb_2022_112826
crossref_primary_10_1093_jrr_rrac016
crossref_primary_10_1093_pcmedi_pbaa038
crossref_primary_10_1111_bcpt_13648
crossref_primary_10_1002_ddr_21994
crossref_primary_10_1016_j_tranon_2022_101348
crossref_primary_10_3390_ijms23179569
crossref_primary_10_1016_j_anireprosci_2022_107158
crossref_primary_10_1016_j_jtemb_2024_127553
crossref_primary_10_1142_S0192415X23500969
crossref_primary_10_1016_j_biopha_2022_112770
crossref_primary_10_1016_j_intimp_2021_107741
crossref_primary_10_1515_znc_2024_0220
crossref_primary_10_1016_j_lfs_2019_116607
crossref_primary_10_3389_fphar_2024_1531288
crossref_primary_10_3390_nu13113834
crossref_primary_10_1016_j_snb_2021_130287
crossref_primary_10_1155_2024_2994194
crossref_primary_10_1155_2022_1932692
crossref_primary_10_1016_j_cbi_2021_109729
crossref_primary_10_3389_fchem_2020_00829
crossref_primary_10_1016_j_phymed_2023_154986
crossref_primary_10_3389_fchem_2022_941367
crossref_primary_10_3390_biom13040686
crossref_primary_10_2147_IJN_S375950
crossref_primary_10_1016_j_phrs_2020_105327
crossref_primary_10_1002_med4_51
crossref_primary_10_1093_femsyr_foac052
crossref_primary_10_1002_advs_202411642
crossref_primary_10_1021_acsnano_3c09316
crossref_primary_10_1038_s41392_020_0123_0
crossref_primary_10_3390_biomedicines9101476
crossref_primary_10_1371_journal_pone_0261370
crossref_primary_10_1016_j_intimp_2019_105847
crossref_primary_10_1016_j_clnu_2022_11_009
crossref_primary_10_1080_14786419_2024_2355590
crossref_primary_10_1080_14728222_2023_2225767
crossref_primary_10_3389_fphar_2021_685002
crossref_primary_10_1016_j_snb_2020_129104
crossref_primary_10_1111_jcmm_17242
crossref_primary_10_1016_j_colsurfb_2022_112481
crossref_primary_10_3390_molecules24142527
crossref_primary_10_3390_antiox10101591
crossref_primary_10_2174_0929867329666220322110348
crossref_primary_10_1002_smll_202307210
crossref_primary_10_1016_j_biopha_2023_114224
crossref_primary_10_1016_j_procbio_2024_01_008
crossref_primary_10_1186_s12935_021_01973_1
crossref_primary_10_3390_nu11092169
crossref_primary_10_2174_1871523021666220328121721
crossref_primary_10_1016_j_jddst_2022_103946
crossref_primary_10_3390_cancers15041192
crossref_primary_10_2174_1389557523666230502143131
crossref_primary_10_1177_09603271211021475
crossref_primary_10_3390_ijms23073757
crossref_primary_10_1134_S000635092006010X
crossref_primary_10_1002_cbf_3911
crossref_primary_10_1016_j_phyplu_2021_100044
crossref_primary_10_1007_s12672_024_01590_0
crossref_primary_10_1080_10286020_2023_2193695
crossref_primary_10_1007_s13105_022_00895_4
crossref_primary_10_1002_ptr_7360
crossref_primary_10_1186_s43088_021_00135_6
crossref_primary_10_1021_acsnano_4c05309
crossref_primary_10_31083_j_fbl2907240
crossref_primary_10_3389_fmed_2022_1032256
crossref_primary_10_3390_nu14020256
crossref_primary_10_3389_fphar_2022_933332
crossref_primary_10_1016_j_jneuroim_2021_577758
crossref_primary_10_3389_fchem_2023_1153729
crossref_primary_10_3390_ijms222111772
crossref_primary_10_1016_j_ijpharm_2020_119899
crossref_primary_10_1002_adhm_202400475
crossref_primary_10_52711_0974_360X_2022_00902
crossref_primary_10_2174_1871520623666230412102532
crossref_primary_10_1002_ptr_7350
crossref_primary_10_3389_fphar_2022_863082
crossref_primary_10_2147_IJN_S410688
crossref_primary_10_1039_D1FO01611C
crossref_primary_10_1155_2023_7214037
crossref_primary_10_2174_1871520620666200228110704
crossref_primary_10_1038_s41419_024_06588_8
crossref_primary_10_1016_j_ejmech_2021_113528
crossref_primary_10_3389_fphar_2024_1348076
crossref_primary_10_1021_acsapm_2c01316
crossref_primary_10_3390_nu14071331
crossref_primary_10_1016_j_prp_2020_153082
crossref_primary_10_1002_jbt_23645
crossref_primary_10_1007_s11095_020_2775_4
crossref_primary_10_1590_1809_6891v23e_72215e
crossref_primary_10_3389_fimmu_2023_1120034
crossref_primary_10_1039_D1BM00283J
crossref_primary_10_1016_j_cartre_2025_100464
crossref_primary_10_3390_antiox11081481
crossref_primary_10_1016_j_procbio_2023_04_011
crossref_primary_10_1016_j_procbio_2022_02_006
crossref_primary_10_1016_j_ijbiomac_2021_05_074
crossref_primary_10_1016_j_biopha_2024_116909
crossref_primary_10_32604_or_2023_042228
crossref_primary_10_1016_j_nantod_2021_101134
crossref_primary_10_3390_chemistry5010017
crossref_primary_10_1590_1809_6891v23e_72715p
Cites_doi 10.1093/carcin/bgs029
10.1080/01926230701320337
10.3892/ol.2015.2946
10.1016/S0360-3016(99)00544-1
10.1016/j.drudis.2010.09.005
10.2174/1381612822666161006151605
10.1095/biolreprod.116.141630
10.1038/cdd.2014.128
10.1002/jcp.25778
10.1002/ptr.5167
10.1006/excr.2001.5381
10.1016/j.toxlet.2012.10.008
10.1080/09553002.2018.1440092
10.1002/ijc.24593
10.1186/1476-4598-7-16
10.1111/jcmm.13701
10.1038/sj.cdd.4401874
10.1007/s11010-013-1752-1
10.1038/cddis.2016.136
10.1002/ptr.5174
10.1007/s00262-011-1008-4
10.1016/S0304-3835(01)00655-3
10.1128/MCB.21.16.5299-5305.2001
10.1002/ijc.30224
10.1007/s10787-016-0301-4
10.1101/gad.1228704
10.1016/j.ccr.2014.07.027
10.2174/1874467211666180619125653
10.3390/ijms140815931
10.1371/journal.pone.0057218
10.1016/j.ijrobp.2010.07.1986
10.1158/1078-0432.CCR-07-4722
10.1093/carcin/bgh163
10.4103/jrcr.jrcr_32_17
10.1002/cam4.54
10.1093/carcin/20.3.445
10.1111/j.1464-410X.2007.06593.x
10.1016/S0014-5793(02)02292-5
10.1016/j.fct.2017.04.007
10.1016/S0928-4680(00)00053-5
10.1073/pnas.96.11.6199
10.1186/s12885-015-1291-0
10.1093/carcin/bgl026
10.1093/carcin/bgi167
10.1016/S0002-9440(10)64681-0
10.1007/s13277-010-0042-8
10.1016/S0006-2952(96)00834-9
10.1016/S0006-2952(00)00391-9
10.1093/oxfordjournals.bmb.a011629
10.1093/carcin/bgi371
10.1158/1535-7163.MCT-09-0290
10.3322/caac.21387
10.1093/abbs/gms074
10.1007/s10555-007-9056-0
10.1038/sj.onc.1207116
10.1186/1757-2215-3-11
10.2174/1381612822666161010115235
10.1016/j.bbrc.2013.10.008
10.1677/erc.1.01171
10.1016/S1383-5718(99)00220-X
10.1038/sj.onc.1209608
10.1002/jcp.26055
10.1016/S0300-9084(02)01376-7
10.4161/cbt.7.4.5534
10.5114/aoms.2017.69326
10.1002/ptr.5659
10.1016/S0753-3322(05)80045-9
10.1016/j.mrgentox.2018.01.007
10.1038/srep08566
10.3390/ijms16022942
10.1016/j.phrs.2016.11.017
10.1016/j.bbalip.2014.09.006
10.1016/S0304-419X(99)00032-3
10.18632/oncotarget.4319
10.1083/jcb.144.2.281
10.1007/s12094-018-1934-0
10.1038/cdd.2015.3
10.1016/j.ccr.2008.02.001
10.1016/j.tranon.2017.05.001
10.1038/nrc1588
10.1007/s00441-001-0479-6
10.1124/mol.107.043554
10.1128/MCB.20.5.1626-1638.2000
10.2174/1874467211666180802164449
10.1038/bjc.2013.53
10.1007/112_2016_3
10.1055/s-0043-100019
10.1038/sj.onc.1207232
10.1002/jcb.27703
10.1097/00001622-200311000-00001
10.1038/s41598-017-16436-9
10.2174/138161210791959818
10.1126/sciadv.1501292
10.2174/1874467211666180219102520
10.1002/jcb.27646
10.1074/jbc.M211010200
10.1093/rheumatology/kei132
10.1016/S0960-7404(97)00015-7
10.1093/carcin/bgh233
10.18632/aging.101121
10.1016/S1470-2045(03)01277-4
10.1038/nrc2587
10.1254/jphs.12149FP
10.1016/j.autrev.2017.11.016
10.3892/or.2015.4258
10.1007/s12272-017-0979-x
10.1016/S1359-6101(03)00029-7
10.1016/j.phrs.2018.09.012
10.1016/j.phrs.2016.03.026
10.1038/364806a0
10.1155/2011/565316
10.1016/j.clnu.2014.12.019
10.1016/j.cellsig.2015.07.022
10.1242/jcs.02554
10.1371/journal.pone.0051309
10.1055/s-0044-101752
10.1007/s12094-013-1135-9
10.3892/ol.2017.6739
10.1016/j.ygyno.2006.10.050
10.1016/j.intimp.2011.12.009
10.1016/j.lfs.2013.01.013
10.1093/carcin/bgh165
10.1038/cdd.2017.169
10.2174/1874467211666181010154709
10.1038/nrd2781
10.1080/10717544.2017.1384863
10.1038/nature04870
10.2147/OTT.S96899
10.3892/ol.2017.6053
10.1016/S1097-2765(03)00050-9
10.1002/jcp.27391
10.1128/MCB.24.3.1007-1021.2004
10.2174/1574362410666150109223303
10.20892/j.issn.2095-3941.2017.0049
10.1074/jbc.M111.256180
10.1038/bjc.2012.498
10.1158/1535-7163.803.3.7
10.1186/s13046-015-0168-z
10.3389/fonc.2013.00120
10.1038/onc.2009.451
10.1186/1472-6882-12-22
10.1158/1078-0432.CCR-05-0885
10.1016/j.cytogfr.2016.10.001
10.5012/bkcs.2014.35.11.3339
10.31661/jbpe.v0i0.713
10.1242/jcs.02579
10.1155/2017/5787218
10.1111/j.1749-6632.2009.04699.x
10.1016/j.phrs.2017.02.008
10.1016/j.jff.2015.01.005
10.1080/095530097143716
10.1186/1750-2187-2-10
10.3322/canjclin.51.5.290
10.1002/ijc.24064
10.1080/01635580903441238
10.1016/S0002-9440(10)64656-1
10.1016/j.cllc.2011.03.007
ContentType Journal Article
Copyright 2019 Wiley Periodicals, Inc.
Copyright_xml – notice: 2019 Wiley Periodicals, Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7U7
8FD
C1K
FR3
K9.
P64
RC3
7X8
DOI 10.1002/jcp.28122
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Technology Research Database
Toxicology Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef

MEDLINE - Academic
Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Biology
EISSN 1097-4652
EndPage 12550
ExternalDocumentID 30623450
10_1002_jcp_28122
JCP28122
Genre reviewArticle
Journal Article
Review
GroupedDBID ---
-DZ
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
36B
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
85S
8UM
930
9M8
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDPE
ABEFU
ABEML
ABIJN
ABJNI
ABPPZ
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACNCT
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BQCPF
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMB
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
H~9
IH2
IX1
J0M
JPC
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M56
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MVM
MXFUL
MXSTM
N04
N05
N9A
NEJ
NF~
NNB
O66
O9-
OHT
OIG
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RWI
RWR
RX1
RYL
S10
SAMSI
SUPJJ
SV3
TN5
TWZ
UB1
UPT
V2E
V8K
VQP
W8V
W99
WBKPD
WH7
WIB
WIH
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WXSBR
WYB
WYISQ
X7M
XG1
XJT
XOL
XPP
XSW
XV2
Y6R
YQT
YZZ
ZGI
ZXP
ZZTAW
~IA
~WT
AAMMB
AAYXX
ADXHL
AEFGJ
AETEA
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7U7
8FD
C1K
FR3
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c3532-c87c60fd1c42d913b9c5240c3ba59b2b5ecabe5578cc208b0e1f52eb9398225f3
IEDL.DBID DR2
ISSN 0021-9541
1097-4652
IngestDate Fri Jul 11 06:04:54 EDT 2025
Fri Jul 18 04:11:43 EDT 2025
Thu Apr 03 07:08:06 EDT 2025
Thu Jul 24 02:00:24 EDT 2025
Thu Apr 24 22:58:18 EDT 2025
Wed Jan 22 16:24:41 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords NF-κB
apoptosis
cancer
JNK
curcumin
p53
Language English
License 2019 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3532-c87c60fd1c42d913b9c5240c3ba59b2b5ecabe5578cc208b0e1f52eb9398225f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-8656-1444
PMID 30623450
PQID 2211498732
PQPubID 1006363
PageCount 14
ParticipantIDs proquest_miscellaneous_2165666308
proquest_journals_2211498732
pubmed_primary_30623450
crossref_citationtrail_10_1002_jcp_28122
crossref_primary_10_1002_jcp_28122
wiley_primary_10_1002_jcp_28122_JCP28122
PublicationCentury 2000
PublicationDate August 2019
2019-08-00
20190801
PublicationDateYYYYMMDD 2019-08-01
PublicationDate_xml – month: 08
  year: 2019
  text: August 2019
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Journal of cellular physiology
PublicationTitleAlternate J Cell Physiol
PublicationYear 2019
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References e_1_2_8_1_36_1
e_1_2_8_1_55_1
e_1_2_8_1_51_1
e_1_2_8_1_70_1
Baatout S. (e_1_2_8_1_14_1) 2004; 24
Somasundaram S. (e_1_2_8_1_155_1) 2002; 62
Chen J. (e_1_2_8_1_32_1) 2015; 3
e_1_2_8_1_124_1
e_1_2_8_1_101_1
e_1_2_8_1_143_1
e_1_2_8_1_105_1
e_1_2_8_1_128_1
e_1_2_8_1_81_1
e_1_2_8_1_166_1
e_1_2_8_1_147_1
e_1_2_8_1_85_1
e_1_2_8_1_162_1
e_1_2_8_1_185_1
e_1_2_8_1_89_1
e_1_2_8_1_120_1
Calaf G. M. (e_1_2_8_1_28_1) 2012; 40
e_1_2_8_1_29_1
e_1_2_8_1_48_1
e_1_2_8_1_181_1
e_1_2_8_1_47_1
e_1_2_8_1_24_1
e_1_2_8_1_66_1
e_1_2_8_1_43_1
e_1_2_8_1_20_1
e_1_2_8_1_62_1
Huang S. (e_1_2_8_1_72_1) 2011; 25
e_1_2_8_1_109_1
Farhood B. (e_1_2_8_1_49_1) 2018
e_1_2_8_1_112_1
e_1_2_8_1_135_1
e_1_2_8_1_158_1
e_1_2_8_1_3_1
Tian F. (e_1_2_8_1_159_1) 2012; 28
Hallman K. (e_1_2_8_1_64_1) 2017; 9
e_1_2_8_1_116_1
e_1_2_8_1_139_1
e_1_2_8_1_154_1
e_1_2_8_1_177_1
e_1_2_8_1_7_1
e_1_2_8_1_93_1
e_1_2_8_1_150_1
e_1_2_8_1_173_1
e_1_2_8_1_74_1
e_1_2_8_1_131_1
e_1_2_8_1_78_1
e_1_2_8_1_17_1
e_1_2_8_1_59_1
e_1_2_8_1_56_1
e_1_2_8_1_10_1
e_1_2_8_1_52_1
e_1_2_8_1_71_1
e_1_2_8_1_8_1
e_1_2_8_1_118_1
e_1_2_8_1_102_1
e_1_2_8_1_121_1
e_1_2_8_1_144_1
e_1_2_8_1_106_1
e_1_2_8_1_82_1
e_1_2_8_1_125_1
e_1_2_8_1_148_1
e_1_2_8_1_167_1
e_1_2_8_1_86_1
e_1_2_8_1_163_1
e_1_2_8_1_186_1
Lee S. H. (e_1_2_8_1_91_1) 2012; 17
e_1_2_8_1_26_1
Girdhani S. (e_1_2_8_1_58_1) 2009; 1
e_1_2_8_1_182_1
e_1_2_8_1_25_1
e_1_2_8_1_44_1
e_1_2_8_1_67_1
e_1_2_8_1_21_1
e_1_2_8_1_63_1
Brown J. M. (e_1_2_8_1_23_1) 1999; 59
Bagheri H. (e_1_2_8_1_15_1) 2018; 43
e_1_2_8_1_129_1
e_1_2_8_1_113_1
e_1_2_8_1_90_1
e_1_2_8_1_132_1
e_1_2_8_1_117_1
e_1_2_8_1_4_1
e_1_2_8_1_136_1
e_1_2_8_1_178_1
Chen X. (e_1_2_8_1_33_1) 2003; 63
e_1_2_8_1_151_1
e_1_2_8_1_75_1
e_1_2_8_1_98_1
e_1_2_8_1_18_1
e_1_2_8_1_37_1
e_1_2_8_1_79_1
e_1_2_8_1_170_1
e_1_2_8_1_11_1
e_1_2_8_1_57_1
Yao Q. (e_1_2_8_1_179_1) 2013; 6
e_1_2_8_1_34_1
Afrin L. B. (e_1_2_8_1_5_1) 2000; 96
e_1_2_8_1_53_1
e_1_2_8_1_30_1
e_1_2_8_1_9_1
e_1_2_8_1_119_1
e_1_2_8_1_145_1
e_1_2_8_1_122_1
e_1_2_8_1_187_1
e_1_2_8_1_103_1
e_1_2_8_1_83_1
e_1_2_8_1_126_1
e_1_2_8_1_168_1
e_1_2_8_1_183_1
e_1_2_8_1_87_1
e_1_2_8_1_164_1
e_1_2_8_1_27_1
Sahebkar A. (e_1_2_8_1_141_1) 2016; 17
Gore E. (e_1_2_8_1_61_1) 2004; 18
e_1_2_8_1_160_1
e_1_2_8_1_22_1
Fogoros S. (e_1_2_8_1_50_1) 2005; 65
e_1_2_8_1_68_1
e_1_2_8_1_45_1
e_1_2_8_1_41_1
e_1_2_8_1_60_1
e_1_2_8_1_107_1
Koohpar Z. K. (e_1_2_8_1_84_1) 2015; 8
e_1_2_8_1_110_1
e_1_2_8_1_133_1
Lev‐Ari S. (e_1_2_8_1_94_1) 2005; 11
Li F. (e_1_2_8_1_97_1) 2010; 1805
e_1_2_8_1_114_1
e_1_2_8_1_137_1
e_1_2_8_1_156_1
e_1_2_8_1_95_1
e_1_2_8_1_19_1
e_1_2_8_1_152_1
e_1_2_8_1_175_1
e_1_2_8_1_76_1
e_1_2_8_1_99_1
Baatout S. (e_1_2_8_1_13_1) 2005; 15
e_1_2_8_1_38_1
e_1_2_8_1_12_1
e_1_2_8_1_35_1
e_1_2_8_1_31_1
e_1_2_8_1_54_1
Balcer‐Kubiczek E. K. (e_1_2_8_1_16_1) 2012; 34
e_1_2_8_1_100_1
e_1_2_8_1_123_1
e_1_2_8_1_146_1
e_1_2_8_1_169_1
Wu S.‐H. (e_1_2_8_1_171_1) 2010; 30
e_1_2_8_1_80_1
e_1_2_8_1_127_1
e_1_2_8_1_165_1
e_1_2_8_1_104_1
e_1_2_8_1_161_1
e_1_2_8_1_184_1
Shankar S. (e_1_2_8_1_149_1) 2007; 30
Deeb D. (e_1_2_8_1_40_1) 2003; 2
e_1_2_8_1_88_1
e_1_2_8_1_142_1
e_1_2_8_1_180_1
e_1_2_8_1_46_1
e_1_2_8_1_69_1
e_1_2_8_1_42_1
e_1_2_8_1_65_1
e_1_2_8_1_108_1
Saha S. (e_1_2_8_1_140_1) 2012; 32
Yahyapour R. (e_1_2_8_1_174_1) 2018; 7
e_1_2_8_1_2_1
e_1_2_8_1_134_1
e_1_2_8_1_111_1
e_1_2_8_1_6_1
e_1_2_8_1_92_1
e_1_2_8_1_138_1
e_1_2_8_1_176_1
e_1_2_8_1_115_1
e_1_2_8_1_73_1
e_1_2_8_1_96_1
e_1_2_8_1_172_1
e_1_2_8_1_153_1
e_1_2_8_1_39_1
e_1_2_8_1_77_1
e_1_2_8_1_130_1
Thompson H. J. (e_1_2_8_1_157_1) 1992; 1
References_xml – volume: 18
  start-page: 10
  issue: 14
  year: 2004
  ident: e_1_2_8_1_61_1
  article-title: Celecoxib and radiation therapy in non‐small‐cell lung cancer
  publication-title: Oncology (Williston Park, NY)
– ident: e_1_2_8_1_65_1
  doi: 10.1093/carcin/bgs029
– ident: e_1_2_8_1_43_1
  doi: 10.1080/01926230701320337
– ident: e_1_2_8_1_100_1
  doi: 10.3892/ol.2015.2946
– ident: e_1_2_8_1_138_1
  doi: 10.1016/S0360-3016(99)00544-1
– volume: 40
  start-page: 436
  issue: 2
  year: 2012
  ident: e_1_2_8_1_28_1
  article-title: Effect of curcumin on irradiated and estrogen‐transformed human breast cell lines
  publication-title: International Journal of Oncology
– volume: 9
  start-page: 153
  year: 2017
  ident: e_1_2_8_1_64_1
  article-title: The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERalpha) in breast cancer cells
  publication-title: Breast Cancer (Dove Medical Press)
– ident: e_1_2_8_1_70_1
  doi: 10.1016/j.drudis.2010.09.005
– ident: e_1_2_8_1_57_1
  doi: 10.2174/1381612822666161006151605
– volume: 8
  start-page: e2331
  issue: 3
  year: 2015
  ident: e_1_2_8_1_84_1
  article-title: Anticancer activity of curcumin on human breast adenocarcinoma: Role of Mcl‐1 gene
  publication-title: Iranian Journal of Cancer Prevention
– ident: e_1_2_8_1_102_1
  doi: 10.1095/biolreprod.116.141630
– ident: e_1_2_8_1_172_1
  doi: 10.1038/cdd.2014.128
– volume: 63
  start-page: 1059
  issue: 5
  year: 2003
  ident: e_1_2_8_1_33_1
  article-title: Differential roles of RelA (p65) and c‐Rel subunits of nuclear factor kappa B in tumor necrosis factor‐related apoptosis‐inducing ligand signaling
  publication-title: Cancer Research
– ident: e_1_2_8_1_4_1
  doi: 10.1002/jcp.25778
– ident: e_1_2_8_1_101_1
  doi: 10.1002/ptr.5167
– ident: e_1_2_8_1_26_1
  doi: 10.1006/excr.2001.5381
– ident: e_1_2_8_1_44_1
  doi: 10.1016/j.toxlet.2012.10.008
– ident: e_1_2_8_1_120_1
  doi: 10.1080/09553002.2018.1440092
– ident: e_1_2_8_1_87_1
  doi: 10.1002/ijc.24593
– ident: e_1_2_8_1_150_1
  doi: 10.1186/1476-4598-7-16
– ident: e_1_2_8_1_162_1
  doi: 10.1111/jcmm.13701
– ident: e_1_2_8_1_22_1
  doi: 10.1038/sj.cdd.4401874
– volume: 11
  start-page: 6738
  issue: 18
  year: 2005
  ident: e_1_2_8_1_94_1
  article-title: Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clinical cancer research: An official journal of the American Association for
  publication-title: Cancer Research
– ident: e_1_2_8_1_131_1
  doi: 10.1007/s11010-013-1752-1
– volume: 3
  start-page: 330
  issue: 21
  year: 2015
  ident: e_1_2_8_1_32_1
  article-title: The critical roles of miR‐21 in anti‐cancer effects of curcumin
  publication-title: Annals of Translational Medicine
– ident: e_1_2_8_1_182_1
  doi: 10.1038/cddis.2016.136
– ident: e_1_2_8_1_125_1
  doi: 10.1002/ptr.5174
– volume: 43
  start-page: 645
  year: 2018
  ident: e_1_2_8_1_15_1
  article-title: Protection against radiation‐induced micronuclei in rat bone marrow erythrocytes by Curcumin and selenium L‐methionine
  publication-title: Iranian Journal of Medical Sciences
– ident: e_1_2_8_1_145_1
  doi: 10.1007/s00262-011-1008-4
– ident: e_1_2_8_1_60_1
  doi: 10.1016/S0304-3835(01)00655-3
– ident: e_1_2_8_1_104_1
  doi: 10.1128/MCB.21.16.5299-5305.2001
– ident: e_1_2_8_1_106_1
  doi: 10.1002/ijc.30224
– ident: e_1_2_8_1_128_1
  doi: 10.1007/s10787-016-0301-4
– ident: e_1_2_8_1_66_1
  doi: 10.1101/gad.1228704
– ident: e_1_2_8_1_160_1
  doi: 10.1016/j.ccr.2014.07.027
– ident: e_1_2_8_1_175_1
  doi: 10.2174/1874467211666180619125653
– ident: e_1_2_8_1_130_1
  doi: 10.3390/ijms140815931
– ident: e_1_2_8_1_147_1
  doi: 10.1371/journal.pone.0057218
– ident: e_1_2_8_1_35_1
  doi: 10.1016/j.ijrobp.2010.07.1986
– ident: e_1_2_8_1_86_1
  doi: 10.1158/1078-0432.CCR-07-4722
– volume: 96
  start-page: 77
  issue: 2
  year: 2000
  ident: e_1_2_8_1_5_1
  article-title: Medical therapy of prostate cancer: 1999
  publication-title: Journal of the South Carolina Medical Association (1975)
– ident: e_1_2_8_1_112_1
  doi: 10.1093/carcin/bgh163
– ident: e_1_2_8_1_39_1
  doi: 10.4103/jrcr.jrcr_32_17
– ident: e_1_2_8_1_153_1
  doi: 10.1002/cam4.54
– ident: e_1_2_8_1_183_1
  doi: 10.1093/carcin/20.3.445
– ident: e_1_2_8_1_6_1
  doi: 10.1111/j.1464-410X.2007.06593.x
– ident: e_1_2_8_1_36_1
  doi: 10.1016/S0014-5793(02)02292-5
– ident: e_1_2_8_1_144_1
  doi: 10.1016/j.fct.2017.04.007
– volume: 59
  start-page: 1391
  issue: 7
  year: 1999
  ident: e_1_2_8_1_23_1
  article-title: Apoptosis, p53, and tumor cell sensitivity to anticancer agents
  publication-title: Cancer Research
– ident: e_1_2_8_1_78_1
  doi: 10.1016/S0928-4680(00)00053-5
– ident: e_1_2_8_1_156_1
  doi: 10.1073/pnas.96.11.6199
– ident: e_1_2_8_1_148_1
  doi: 10.1186/s12885-015-1291-0
– ident: e_1_2_8_1_77_1
  doi: 10.1093/carcin/bgl026
– ident: e_1_2_8_1_76_1
  doi: 10.1093/carcin/bgi167
– ident: e_1_2_8_1_88_1
  doi: 10.1016/S0002-9440(10)64681-0
– volume: 30
  start-page: 905
  issue: 4
  year: 2007
  ident: e_1_2_8_1_149_1
  article-title: Involvement of Bcl‐2 family members, phosphatidylinositol 3'‐kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)‐induced apoptosis in prostate cancer
  publication-title: International Journal of Oncology
– ident: e_1_2_8_1_45_1
  doi: 10.1007/s13277-010-0042-8
– volume: 7
  start-page: 0
  issue: 3
  year: 2018
  ident: e_1_2_8_1_174_1
  article-title: Metformin protects against radiation‐induced heart injury and attenuates the up‐regulation of dual oxidase genes following rat's chest irradiation
  publication-title: International Journal of Molecular and Cellular Medicine
– ident: e_1_2_8_1_133_1
  doi: 10.1016/S0006-2952(96)00834-9
– ident: e_1_2_8_1_21_1
  doi: 10.1016/S0006-2952(00)00391-9
– ident: e_1_2_8_1_63_1
  doi: 10.1093/oxfordjournals.bmb.a011629
– ident: e_1_2_8_1_114_1
  doi: 10.1093/carcin/bgi371
– volume: 1
  start-page: 208
  issue: 4
  year: 2009
  ident: e_1_2_8_1_58_1
  article-title: Enhancement of gamma radiation‐induced cytotoxicity of breast cancer cells by curcumin
  publication-title: Molecular and Cellular Pharmacology
– ident: e_1_2_8_1_82_1
  doi: 10.1158/1535-7163.MCT-09-0290
– ident: e_1_2_8_1_152_1
  doi: 10.3322/caac.21387
– ident: e_1_2_8_1_158_1
  doi: 10.1093/abbs/gms074
– ident: e_1_2_8_1_108_1
  doi: 10.1007/s10555-007-9056-0
– ident: e_1_2_8_1_51_1
  doi: 10.1038/sj.onc.1207116
– ident: e_1_2_8_1_176_1
  doi: 10.1186/1757-2215-3-11
– ident: e_1_2_8_1_181_1
  doi: 10.2174/1381612822666161010115235
– ident: e_1_2_8_1_180_1
  doi: 10.1016/j.bbrc.2013.10.008
– ident: e_1_2_8_1_111_1
  doi: 10.1677/erc.1.01171
– ident: e_1_2_8_1_10_1
  doi: 10.1016/S1383-5718(99)00220-X
– volume: 34
  start-page: 277
  issue: 3
  year: 2012
  ident: e_1_2_8_1_16_1
  article-title: Apoptosis in radiation therapy: A double‐edged sword
  publication-title: Experimental Oncology
– ident: e_1_2_8_1_54_1
  doi: 10.1038/sj.onc.1209608
– ident: e_1_2_8_1_107_1
  doi: 10.1002/jcp.26055
– ident: e_1_2_8_1_27_1
  doi: 10.1016/S0300-9084(02)01376-7
– volume: 17
  start-page: 1192
  issue: 6
  year: 2016
  ident: e_1_2_8_1_141_1
  article-title: Analgesic efficacy and safety of curcuminoids in clinical practice: A systematic review and meta‐analysis of randomized controlled trials
  publication-title: Pain Medicine (United States)
– volume: 30
  start-page: 2125
  issue: 6
  year: 2010
  ident: e_1_2_8_1_171_1
  article-title: Curcumin induces apoptosis in human non‐small cell lung cancer NCI‐H460 cells through ER stress and caspase cascade‐ and mitochondria‐dependent pathways
  publication-title: Anticancer Research
– ident: e_1_2_8_1_11_1
  doi: 10.4161/cbt.7.4.5534
– ident: e_1_2_8_1_37_1
  doi: 10.5114/aoms.2017.69326
– ident: e_1_2_8_1_137_1
  doi: 10.1002/ptr.5659
– ident: e_1_2_8_1_95_1
  doi: 10.1016/S0753-3322(05)80045-9
– volume: 32
  start-page: 2567
  issue: 7
  year: 2012
  ident: e_1_2_8_1_140_1
  article-title: Death by design: Where curcumin sensitizes drug‐resistant tumours
  publication-title: Anticancer Research
– volume: 28
  start-page: 232
  issue: 1
  year: 2012
  ident: e_1_2_8_1_159_1
  article-title: Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice
  publication-title: Oncology Reports
– ident: e_1_2_8_1_119_1
  doi: 10.1016/j.mrgentox.2018.01.007
– ident: e_1_2_8_1_169_1
  doi: 10.1038/srep08566
– ident: e_1_2_8_1_83_1
  doi: 10.3390/ijms16022942
– ident: e_1_2_8_1_93_1
  doi: 10.1016/j.phrs.2016.11.017
– ident: e_1_2_8_1_3_1
  doi: 10.1016/j.bbalip.2014.09.006
– ident: e_1_2_8_1_164_1
  doi: 10.1016/S0304-419X(99)00032-3
– ident: e_1_2_8_1_99_1
  doi: 10.18632/oncotarget.4319
– ident: e_1_2_8_1_154_1
  doi: 10.1083/jcb.144.2.281
– ident: e_1_2_8_1_48_1
  doi: 10.1007/s12094-018-1934-0
– ident: e_1_2_8_1_134_1
  doi: 10.1038/cdd.2015.3
– ident: e_1_2_8_1_42_1
  doi: 10.1016/j.ccr.2008.02.001
– ident: e_1_2_8_1_19_1
  doi: 10.1016/j.tranon.2017.05.001
– ident: e_1_2_8_1_121_1
  doi: 10.1038/nrc1588
– ident: e_1_2_8_1_146_1
  doi: 10.1007/s00441-001-0479-6
– ident: e_1_2_8_1_74_1
  doi: 10.1124/mol.107.043554
– ident: e_1_2_8_1_103_1
  doi: 10.1128/MCB.20.5.1626-1638.2000
– ident: e_1_2_8_1_9_1
  doi: 10.2174/1874467211666180802164449
– ident: e_1_2_8_1_29_1
  doi: 10.1038/bjc.2013.53
– ident: e_1_2_8_1_109_1
  doi: 10.1007/112_2016_3
– ident: e_1_2_8_1_127_1
  doi: 10.1055/s-0043-100019
– ident: e_1_2_8_1_166_1
  doi: 10.1038/sj.onc.1207232
– ident: e_1_2_8_1_46_1
  doi: 10.1002/jcb.27703
– ident: e_1_2_8_1_56_1
  doi: 10.1097/00001622-200311000-00001
– volume: 17
  start-page: 19
  issue: 1
  year: 2012
  ident: e_1_2_8_1_91_1
  article-title: Apoptotic effects of curcumin via the regulation of COX‐2/VASP signaling molecules in MCF‐7 breast cancer cells
  publication-title: Cancer Prevention Research
– ident: e_1_2_8_1_34_1
  doi: 10.1038/s41598-017-16436-9
– ident: e_1_2_8_1_8_1
  doi: 10.2174/138161210791959818
– ident: e_1_2_8_1_52_1
  doi: 10.1126/sciadv.1501292
– ident: e_1_2_8_1_31_1
  doi: 10.2174/1874467211666180219102520
– ident: e_1_2_8_1_118_1
  doi: 10.1002/jcb.27646
– ident: e_1_2_8_1_139_1
  doi: 10.1074/jbc.M211010200
– volume: 6
  start-page: 2342
  issue: 11
  year: 2013
  ident: e_1_2_8_1_179_1
  article-title: Protective effect of curcumin on chemotherapy‐induced intestinal dysfunction
  publication-title: International Journal of Clinical and Experimental Pathology
– ident: e_1_2_8_1_96_1
  doi: 10.1093/rheumatology/kei132
– volume: 15
  start-page: 337
  issue: 2
  year: 2005
  ident: e_1_2_8_1_13_1
  article-title: Increased radiation sensitivity of an eosinophilic cell line following treatment with epigallocatechin‐gallate, resveratrol and curcuma
  publication-title: International Journal of Molecular Medicine
– ident: e_1_2_8_1_20_1
  doi: 10.1016/S0960-7404(97)00015-7
– ident: e_1_2_8_1_38_1
  doi: 10.1093/carcin/bgh233
– ident: e_1_2_8_1_185_1
  doi: 10.18632/aging.101121
– ident: e_1_2_8_1_71_1
  doi: 10.1016/S1470-2045(03)01277-4
– ident: e_1_2_8_1_17_1
  doi: 10.1038/nrc2587
– ident: e_1_2_8_1_135_1
  doi: 10.1254/jphs.12149FP
– ident: e_1_2_8_1_110_1
  doi: 10.1016/j.autrev.2017.11.016
– volume: 1
  start-page: 597
  issue: 7
  year: 1992
  ident: e_1_2_8_1_157_1
  article-title: Apoptosis in the genesis and prevention of cancer. Cancer epidemiology, biomarkers & prevention: A publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive
  publication-title: Oncology
– ident: e_1_2_8_1_75_1
  doi: 10.3892/or.2015.4258
– year: 2018
  ident: e_1_2_8_1_49_1
  article-title: Disruption of the redox balance with either oxidative or anti‐oxidative overloading as a promising target for cancer therapy
  publication-title: Journal of Cellular Biochemistry
– ident: e_1_2_8_1_170_1
  doi: 10.1007/s12272-017-0979-x
– ident: e_1_2_8_1_7_1
  doi: 10.1016/S1359-6101(03)00029-7
– ident: e_1_2_8_1_132_1
  doi: 10.1016/j.phrs.2018.09.012
– ident: e_1_2_8_1_143_1
  doi: 10.1016/j.phrs.2016.03.026
– ident: e_1_2_8_1_122_1
  doi: 10.1038/364806a0
– volume: 65
  start-page: 1164
  issue: 9
  year: 2005
  ident: e_1_2_8_1_50_1
  article-title: Inhibition of NF‐kB enhances chemotherapy induced apoptosis in ovarian cancer cells
  publication-title: Cancer Research
– ident: e_1_2_8_1_73_1
  doi: 10.1155/2011/565316
– volume: 25
  issue: 1
  year: 2011
  ident: e_1_2_8_1_72_1
  article-title: Curcumin induces apoptosis by suppressing protein phosphatase 5 leading to activation of JNK cascade
  publication-title: Federation of American Societies for Experimental Biology
– ident: e_1_2_8_1_126_1
  doi: 10.1016/j.clnu.2014.12.019
– ident: e_1_2_8_1_2_1
  doi: 10.1016/j.cellsig.2015.07.022
– ident: e_1_2_8_1_115_1
  doi: 10.1242/jcs.02554
– volume: 1805
  start-page: 167
  issue: 2
  year: 2010
  ident: e_1_2_8_1_97_1
  article-title: Targeting transcription factor NF‐kappaB to overcome chemoresistance and radioresistance in cancer therapy
  publication-title: Biochimica et Biophysica Acta
– ident: e_1_2_8_1_124_1
  doi: 10.1371/journal.pone.0051309
– ident: e_1_2_8_1_129_1
  doi: 10.1055/s-0044-101752
– ident: e_1_2_8_1_186_1
  doi: 10.1007/s12094-013-1135-9
– ident: e_1_2_8_1_113_1
  doi: 10.3892/ol.2017.6739
– ident: e_1_2_8_1_165_1
  doi: 10.1016/j.ygyno.2006.10.050
– ident: e_1_2_8_1_123_1
  doi: 10.1016/j.intimp.2011.12.009
– ident: e_1_2_8_1_167_1
  doi: 10.1016/j.lfs.2013.01.013
– ident: e_1_2_8_1_69_1
  doi: 10.1093/carcin/bgh165
– ident: e_1_2_8_1_12_1
  doi: 10.1038/cdd.2017.169
– ident: e_1_2_8_1_81_1
  doi: 10.2174/1874467211666181010154709
– ident: e_1_2_8_1_18_1
  doi: 10.1038/nrd2781
– ident: e_1_2_8_1_178_1
  doi: 10.1080/10717544.2017.1384863
– volume: 24
  start-page: 321
  issue: 2
  year: 2004
  ident: e_1_2_8_1_14_1
  article-title: Effect of curcuma on radiation‐induced apoptosis in human cancer cells
  publication-title: International Journal of Oncology
– ident: e_1_2_8_1_80_1
  doi: 10.1038/nature04870
– ident: e_1_2_8_1_90_1
  doi: 10.2147/OTT.S96899
– ident: e_1_2_8_1_168_1
  doi: 10.3892/ol.2017.6053
– ident: e_1_2_8_1_105_1
  doi: 10.1016/S1097-2765(03)00050-9
– ident: e_1_2_8_1_47_1
  doi: 10.1002/jcp.27391
– ident: e_1_2_8_1_163_1
  doi: 10.1128/MCB.24.3.1007-1021.2004
– ident: e_1_2_8_1_184_1
  doi: 10.2174/1574362410666150109223303
– ident: e_1_2_8_1_161_1
  doi: 10.20892/j.issn.2095-3941.2017.0049
– ident: e_1_2_8_1_25_1
  doi: 10.1074/jbc.M111.256180
– ident: e_1_2_8_1_30_1
  doi: 10.1038/bjc.2012.498
– ident: e_1_2_8_1_41_1
  doi: 10.1158/1535-7163.803.3.7
– ident: e_1_2_8_1_98_1
  doi: 10.1186/s13046-015-0168-z
– ident: e_1_2_8_1_59_1
  doi: 10.3389/fonc.2013.00120
– ident: e_1_2_8_1_136_1
  doi: 10.1038/onc.2009.451
– volume: 2
  start-page: 95
  issue: 1
  year: 2003
  ident: e_1_2_8_1_40_1
  article-title: Curcumin (diferuloyl‐methane) enhances tumor necrosis factor‐related apoptosis‐inducing ligand‐induced apoptosis in lncap prostate cancer cells1
  publication-title: Molecular Cancer Therapeutics
– ident: e_1_2_8_1_177_1
  doi: 10.1186/1472-6882-12-22
– ident: e_1_2_8_1_24_1
  doi: 10.1158/1078-0432.CCR-05-0885
– ident: e_1_2_8_1_79_1
  doi: 10.1016/j.cytogfr.2016.10.001
– ident: e_1_2_8_1_89_1
  doi: 10.5012/bkcs.2014.35.11.3339
– ident: e_1_2_8_1_173_1
  doi: 10.31661/jbpe.v0i0.713
– ident: e_1_2_8_1_116_1
  doi: 10.1242/jcs.02579
– ident: e_1_2_8_1_187_1
  doi: 10.1155/2017/5787218
– ident: e_1_2_8_1_92_1
  doi: 10.1111/j.1749-6632.2009.04699.x
– ident: e_1_2_8_1_55_1
  doi: 10.1016/j.phrs.2017.02.008
– ident: e_1_2_8_1_142_1
  doi: 10.1016/j.jff.2015.01.005
– volume: 62
  start-page: 3868
  issue: 13
  year: 2002
  ident: e_1_2_8_1_155_1
  article-title: Dietary curcumin inhibits chemotherapy‐induced apoptosis in models of human breast cancer
  publication-title: Cancer Research
– ident: e_1_2_8_1_67_1
  doi: 10.1080/095530097143716
– ident: e_1_2_8_1_151_1
  doi: 10.1186/1750-2187-2-10
– ident: e_1_2_8_1_85_1
  doi: 10.3322/canjclin.51.5.290
– ident: e_1_2_8_1_53_1
  doi: 10.1002/ijc.24064
– ident: e_1_2_8_1_68_1
  doi: 10.1080/01635580903441238
– ident: e_1_2_8_1_117_1
  doi: 10.1016/S0002-9440(10)64656-1
– ident: e_1_2_8_1_62_1
  doi: 10.1016/j.cllc.2011.03.007
SSID ssj0009933
Score 2.6670265
SecondaryResourceType review_article
Snippet Cancer incidences are growing and cause millions of deaths worldwide. Cancer therapy is one of the most important challenges in medicine. Improving therapeutic...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 12537
SubjectTerms 1-Phosphatidylinositol 3-kinase
Animals
Antibodies
Apoptosis
Apoptosis - drug effects
Cancer
Cancer therapies
Cell membranes
Cell proliferation
Chemoresistance
Chemotherapy
Curcumin
Curcumin - pharmacology
Gene expression
Gene Expression Regulation, Neoplastic - drug effects
Growth factors
Humans
Immunomodulation
JNK
Mitochondria
Modulation
Molecular modelling
Neoplasms - drug therapy
NF‐κB
p53
p53 Protein
Quality of life
Radiation therapy
Radioresistance
Reactive oxygen species
Receptors
Redox reactions
Signal transduction
Signaling
Transforming growth factor
Transforming growth factor-b
Tumor cell lines
Tumors
Title Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcp.28122
https://www.ncbi.nlm.nih.gov/pubmed/30623450
https://www.proquest.com/docview/2211498732
https://www.proquest.com/docview/2165666308
Volume 234
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9KoeCL2taP0yqriPiSa7Ifuaw-lWKphaqIhT4IYXduD656yXG5PJx_vbO7SWr9APEtsBN2szuz-5vNzG8AXuSafAwhdYKmIAeFjrBE54VMrDbohJKEeH2C8_n7_PRCnl2qyy140-fCRH6I4cLNW0bYr72BG9scXpOGXuFyzOl48vuvj9XygOjTNXWU7srIhxAEJbOeVSjlh8ObN8-i3wDmTbwaDpyTO_ClH2qMM_k6btd2jN9_YXH8z2-5C7c7IMqOoubswpar9mD_qCInfLFhL1kIDQ137nuwEytWbvbhw7nzqcLzZtGwesbMsl6u62besEU97QqBMbth2K6wXcyr1-zdTxHrjAAyQ69mKxbzvjb34OLk7efj06SryZCgUIInWEwwT2fTDCWf6kxYjYpAAQprlLbcKofGOkX7ACJPC5u6bKa4s1p4okA1E_dhu6or9xCYtlbriVXIpZPaknDuhDaZD2QxaTEZwat-dUrsCMt93YxvZaRa5iVNWxmmbQTPB9FlZOn4k9BBv8RlZ6hNyckBlrqYCGp-NjSTifn_JqZydUsynqGIkFlajOBBVI2hF_K4uJAqpcGGBf579-XZ8cfw8OjfRR_DLQJoOgYcHsD2etW6JwSC1vZp0PYfxJgBKQ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRQguFFoeWwoYhBCXbBM_sjHiUlVU29ItCLVSLyiKZ73S0m6y2mwO21_fsfMo5SEhbpE8kR17xv7GmfkG4G2syccQUgeYJeSg0BEW6DiRgdEZWqEkIV6X4Dw6iYdn8uhcna_BxzYXpuaH6C7cnGX4_doZuLuQ3r1hDf2B8z6n84k24Duuord3qL7dkEfpppC8D0JQMmp5hUK-2716-zT6DWLeRqz-yDnYgO_tYOtIk4t-tTR9vPqFx_F_v-YhPGiwKNurlecRrNl8E7b2cvLDZyv2jvnoUH_tvgl366KVqy34MrIuW3hazkpWTFg2L-bLopyWbFaMm1pgzKwYVgusZtP8Azv8KWidEUZm6DRtwerUr9VjODv4dLo_DJqyDAEKJXiAyQDjcDKOUPKxjoTRqAgXoDCZ0oYbZTEzVtFWgMjDxIQ2mihujRaOK1BNxBNYz4vcPgOmjdF6YBRyaaU2JBxbobPIxbJkYTLowft2eVJsOMtd6YzLtGZb5ilNW-qnrQdvOtF5TdTxJ6Gddo3TxlbLlJMPLHUyENT8umsmK3O_TrLcFhXJOJIiAmdh0oOntW50vZDTxYVUIQ3Wr_Dfu0-P9r_6h-1_F30F94ano-P0-PDk83O4T3hN1_GHO7C-XFT2BWGipXnpVf8azRMFRA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRSAuFFoeWwoYhBCXbBM_sjGcqpZVW2ipEJV6qBTFXkda2k2izeaw_fUd20lKeUiIWyRPZMeesb9xZr4BeBtL9DEYl4HOEnRQ8AgLZJzwQMlMGyY4Il6b4Hx0HO-f8sMzcbYCH7tcGM8P0V-4Wctw-7U18GqSb9-Qhv7Q1ZDi8YT77x0eh4lV6b1vN9xRsq0j72IQBI86WqGQbvev3j6MfkOYtwGrO3HGa3DejdUHmlwMm4Ua6qtfaBz_82MewoMWiZIdrzqPYMUU67CxU6AXPluSd8TFhrpL93W460tWLjfg65GxucLTelaTMidZVVaLsp7WZFZO2kpgRC2Jbua6mU2LD-Tgp5B1ggiZaKtnc-ITv5aP4XT86fvuftAWZQg0E4wGOhnpOMwnkeZ0IiOmpBaICjRTmZCKKmF0pozAjUBrGiYqNFEuqFGSWaZAkbMnsFqUhXkGRCol5UgJTbnhUqFwbJjMIhvJkoXJaADvu9VJdctYbgtnXKaea5mmOG2pm7YBvOlFK0_T8SehrW6J09ZS65SiB8xlMmLY_LpvRhuzP06ywpQNyliKIoRmYTKAp141-l7Q5aKMixAH6xb4792nh7sn7mHz30Vfwb2TvXH65eD483O4j2BN-uDDLVhdzBvzAgHRQr10in8N14MD_A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mechanisms+of+apoptosis+modulation+by+curcumin%3A+Implications+for+cancer+therapy&rft.jtitle=Journal+of+cellular+physiology&rft.au=Mortezaee%2C+Keywan&rft.au=Salehi%2C+Ensieh&rft.au=Mirtavoos%E2%80%90mahyari%2C+Hanifeh&rft.au=Motevaseli%2C+Elahe&rft.date=2019-08-01&rft.issn=0021-9541&rft.eissn=1097-4652&rft.volume=234&rft.issue=8&rft.spage=12537&rft.epage=12550&rft_id=info:doi/10.1002%2Fjcp.28122&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_jcp_28122
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9541&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9541&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9541&client=summon